EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis

Alper Doğanci iD, Şebnem Ataman iD, Ali Erhan Özdemirel iD, Recep Bülent Seçkin iD, Ayşe Peyman Yalçin iD, Sevim Bavbek iD

Turkish Journal of Medical Sciences · 10.12.2024 · 54 (6) · 1310-1318

DOI: 10.55730/1300-0144.5914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 10.12.2024. Verfasst von Alper Doğanci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkiye. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Spondylitis, Ankylosing, Adalimumab, Etanercept. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aim: We aimed to investigate the relationship between serum anti-drug antibody (ADAb), hypersensitivity reactions (HSRs) to anti-tumor necrosis factors (anti-TNFs) drugs and to detect the role of skin tests in the diagnosis of HSRs against anti-TNFs.Material and methods: 69 ankylosing spondilitis (AS) and 46 rheumatoid artritis (RA) patients using infliximab, adalimumab, and etanercept were enrolled. Disease activity scores for AS and RA patients were assessed. Serum levels of anti-TNFs and ADAb to these agents were measured with the ELISA.These blood samples were taken 24 hours before the next drug dose.The patients with anti-TNF-associated HSRs were evaluated with a skin prick test (SPT) and intradermal test (IDT). Readings for SPT and IDT were conducted after 15 min, 24, 48, and 72 hours. Heel diameter of 3 mm or more, greater than negative control was considered positive for SPT, and if the size of the initial wheal had increased by at least 3 mm in diameter and was surrounded by erythema was considered positive for IDT. Symptoms such as urticaria/angioedema, flushing, etc. were considered immediate type HSRs. Findings developed at the injection site such as swelling, erythema, etc were considered injection site reactions (ISRs). An overall p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSpondylitis, AnkylosingAdalimumabEtanerceptSkin TestsInfliximabAntirheumatic AgentsDrug HypersensitivityHumansFemaleMaleAdultMiddle AgedTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

Hypersensitivity reactionimmunogenicityintradermal testserum antidrug antibodiesskin prick test

Substanzen

AdalimumabEtanerceptInfliximabAntirheumatic AgentsTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkiye.
  • Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Ankara University, Ankara, Turkiye.
  • Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Ankara Liv Hospital, Ankara, Turkiye.
  • Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Ankara University, Ankara, Turkiye.
  • Division of Clinical Immunology and Allergy, Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkiye.

ORCID-Profile: Alper Doğanci, Şebnem Ataman, Ali Erhan Özdemirel, Recep Bülent Seçkin, Ayşe Peyman Yalçin, Sevim Bavbek

Zitieren

APA

Doğanci, A., Ataman, Ş., Özdemirel, A. E., Seçkin, R. B., Yalçin, A. P., & Bavbek, S. (2024). The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis. Turkish Journal of Medical Sciences, 54(6), 1310-1318. https://doi.org/10.55730/1300-0144.5914

Vancouver

Doğanci A, Ataman Ş, Özdemirel AE, Seçkin RB, Yalçin AP, Bavbek S. The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis. Turkish Journal of Medical Sciences. 2024;54(6):1310-1318. doi:10.55730/1300-0144.5914

BibTeX
@article{Doanci2024,
  author = {Doğanci, Alper and Ataman, Şebnem and Özdemirel, Ali Erhan and Seçkin, Recep Bülent and Yalçin, Ayşe Peyman and Bavbek, Sevim},
  title = {The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis},
  journal = {Turkish Journal of Medical Sciences},
  year = {2024},
  volume = {54},
  number = {6},
  pages = {1310--1318},
  doi = {10.55730/1300-0144.5914}
}
Kostenlos starten →